Literature DB >> 6400706

The absorption of subcutaneously injected short-acting soluble insulin: influence of injection technique and concentration.

P Hildebrandt1, L Sestoft, S L Nielsen.   

Abstract

The effect of injection technique on the absorption of subcutaneously injected short-acting insulin [125I-labeled Actrapid (MC), Novo, Copenhagen, Denmark] was investigated in insulin-dependent diabetic patients. In one side of the abdomen insulin was given with a fixed standard technique. In the other side of the abdomen the temperature of the injected insulin, the depth of injection, and the duration of injection were varied. Furthermore, we compared the absorption of U40 and U100 insulin by giving either 8 U of the two insulins or 0.1 ml of both insulins simultaneously to the patients in either side of the abdomen. With regard to the injection technique the only significant finding was a faster absorption rate with deep (12 mm) than with superficial (3 mm) injection. The absorption of U100 insulin was significantly slower than of U40 insulin, when given in the same amount (8 U) as well as in the same volume (0.1 ml).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6400706     DOI: 10.2337/diacare.6.5.459

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  8 in total

1.  Lymphatic absorption is a significant contributor to the subcutaneous bioavailability of insulin in a sheep model.

Authors:  S A Charman; D N McLennan; G A Edwards; C J Porter
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

Review 2.  Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Authors:  Miroslav Dostalek; Fatemeh Akhlaghi; Martina Puzanovova
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

3.  The pharmacokinetics of two different concentrations of short-acting insulin, intermediate-acting insulin, and an insulin mixture following subcutaneous injection.

Authors:  A Hübinger; W Weber; W Jung; K Wehmeyer; F A Gries
Journal:  Clin Investig       Date:  1992-07

4.  A subcutaneous insulin pharmacokinetic model for computer simulation in a diabetes decision support role: model structure and parameter identification.

Authors:  Jason Wong; J Geoffrey Chase; Christopher E Hann; Geoffrey M Shaw; Thomas F Lotz; Jessica Lin; Aaron J Le Compte
Journal:  J Diabetes Sci Technol       Date:  2008-07

5.  Influence of aprotinin on insulin absorption and subcutaneous blood flow in type 1 (insulin-dependent) diabetes.

Authors:  B Linde; R Gunnarsson
Journal:  Diabetologia       Date:  1985-09       Impact factor: 10.122

6.  Growth hormone therapy with a new delivery system.

Authors:  J T Jørgensen; S Susgaard
Journal:  Indian J Pediatr       Date:  1991 Sep-Oct       Impact factor: 1.967

7.  Interval between insulin injection and eating in relation to blood glucose control in adult diabetics.

Authors:  M E Lean; L L Ng; B R Tennison
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-12

8.  Pharmacokinetics and pharmacodynamics of high-dose human regular U-500 insulin versus human regular U-100 insulin in healthy obese subjects.

Authors:  Amparo de la Peña; Matthew Riddle; Linda A Morrow; Honghua H Jiang; Helle Linnebjerg; Adam Scott; Khin M Win; Marcus Hompesch; Kenneth F Mace; Jennie G Jacobson; Jeffrey A Jackson
Journal:  Diabetes Care       Date:  2011-10-12       Impact factor: 19.112

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.